The FDA has issued a recall for certain eye drops after receiving a consumer complaint.


December 26, 2024 Tags:

Systane Lubricant Eye Drops have been voluntarily recalled following a discovery of possible fungal contamination, the U.S. Food and Drug Administration (FDA) announced. The recall affects one batch of the product, specifically the Systane Lubricant Eye Drops Ultra PF, which were sold in single-use vials. The decision to recall the product was prompted by a consumer complaint about foreign material found inside one of the sealed vials.
The FDA's investigation revealed that the foreign material in question was fungal in nature, leading to the decision to pull the affected lot from the market. This fungal contamination presents a serious risk to users, especially those with weakened immune systems. If the contaminated drops are used, they could potentially cause eye infections that might result in vision loss or, in very rare cases, even be life-threatening for individuals with compromised immune systems.

Alcon Laboratories, the company responsible for manufacturing the Systane eye drops, has emphasized that there have been no reports of adverse effects or illnesses linked to the product thus far. The company reassured the public that the contamination appeared to be isolated to the single vial returned by a customer, and the recall was issued as a precautionary measure to prioritize the safety of consumers.

The affected batch of Systane eye drops comes in a 25-count package of on-the-go single-use vials. These vials have a lot number of 10101 and an expiration date of September 2025. The product was sold primarily at Publix grocery stores, which has issued a notice about the recall.

Systane eye drops are commonly used to treat dryness and irritation in the eyes, providing relief from the burning and discomfort that often accompanies dry eye symptoms. They are typically sold in small, portable vials for convenience, especially for people who need to manage their dry eye condition while on the go.

Consumers who have purchased the recalled product are urged to stop using it immediately. They can return the product to the place of purchase for a refund or replacement. The FDA also advises that anyone who has used the recalled eye drops and is experiencing symptoms, such as eye discomfort or irritation, should seek medical attention from a healthcare provider promptly.

Alcon, in response to the recall, assured that it is conducting an ongoing investigation to understand the root cause of the contamination. However, they stated that the foreign material seems to be limited to the single unit that was returned. As a result, the company took the necessary step to recall the affected batch out of an abundance of caution, ensuring that the safety and well-being of consumers remain a top priority.

The recall of Systane eye drops highlights the importance of vigilance when it comes to product safety, particularly for items that come in direct contact with sensitive areas like the eyes. While the recall seems to be isolated to a specific lot, it serves as a reminder to consumers to always check product labels and lot numbers, especially in the case of medical products.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

You may also like

Mexico Struggles with Measles Outbreak in Mennonite Community

In a white Nissan, Sandra Aguirre and her team navigate through vast apple orchards and cornfields, making their way to....

New Study Rules Out Mystery Neurological Disease in New Brunswick

A major scientific study has concluded that there is no mysterious brain disease spreading across New Brunswick, despite earlier alarming....

Measles Case Reported in Halifax Area: Nova Scotia's First of 2025

Nova Scotia has confirmed its first case of measles for 2025, following a rise in outbreaks across various provinces. Dr.....

Asthma Emergencies Rose Sharply During Ontario’s Wildfire Smoke

Experts Say Awareness and Action Can Help Avoid Hospital Visits A new study has revealed a striking rise in asthma-related....

Doctors Raise Alarm as Measles Cases Surge in Ontario and Alberta

Medical experts are sounding the alarm as measles outbreaks continue to spread rapidly across Ontario and Alberta. They’re urging public....

U.S. Measles Cases Near 900 Amid Ongoing Outbreaks in Multiple States

Measles is making a dangerous comeback across the U.S., with nearly 900 cases reported so far in 2025. The Centers....

Federal Judge Halts Nevada Law on Parental Notification for Minors’ Abortion

A Nevada law requiring parents or guardians to be notified before a minor can undergo an abortion will not take....

FDA Review of Novavax COVID-19 Shot Sparks Doubts on Other Vaccines

A surprise move by the FDA is clouding the future of the Novavax COVID-19 shot (vaccine) and raising concerns about....

U.S. Food Industry Faces Pressure to Eliminate Artificial Dyes

As the demand for natural food colors rises, changes may begin in unexpected places, like Abby Tampow’s lab. On a....

Alberta Health Issues Measles Alert for Southern Region, Including Calgary

Alberta Health Services (AHS) has released a public health notice following a recent spike in confirmed measles cases in southern....

U.S. Pushes to Remove Artificial Dyes from Foods by 2026

In a move aimed at improving children’s health, U.S. health officials announced plans to eliminate artificial food dyes from the....

Pandemic Delays in Cancer Screenings Show Minimal Long-Term Impact, Study finds

A new report reveals that delays in cancer screenings during the early days of the COVID-19 pandemic may not have....